Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Pharma's annual climate report: ambition to execution
As pharma raced to meet climate targets in 2024-2025, it’s proving that scaling medicines doesn’t have to hurt the planet.
Read more
Pharma's annual climate report: ambition to execution
As pharma raced to meet climate targets in 2024-2025, it’s proving that scaling medicines doesn’t have to hurt the planet.
Unwrap the best of pharma
It’s time for Unwrapped 2025. Explore pharma’s defining moments, our Word of the Year and a challenging brain teaser.
Supporting better COPD care through interactive innovation
Explore this case study on how EMJ and PARI GmbH worked together on one of COPD care’s most persistent challenges.
Daiichi Sankyo's Dr Michael Zaiac on moving beyond 'sick care'
Daiichi Sankyo’s Dr Michael Zaiac discusses how AI, biomarkers and targeted therapies are shaping oncology.
Pharma in Spain
Spain’s pharma sector is a hub for clinical trials, exports and digital innovation, but reforms remain key.
AZ's Dr Vikram Chand on advancing equity in cancer care
In our latest Catalyst interview, AstraZeneca’s Dr Vikram Chand delves into improving outcomes in breast cancer.
5 minutes with Benedikt von Thüngen, CEO, Sanome
Benedikt von Thüngen, Founder and CEO, Sanome, shares the origin story of his business and its biggest challenge.
Pharma's role in building next-gen patient case studies
As HCPs seek richer learning experiences, interactive patient case studies are bridging the gap.
Loading posts...
1
2
3
…
36
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View